Companies that reported the most in general payments in 2023

Download CSV · 50 rows Free, no sign-in. Raw amounts in U.S. dollars; the second row says where the data came from.

• BioNTech SE 11.1% of the year $367,885,405 · 201 payments
• AbbVie, Inc. 5.6% of the year $187,442,971 · 1,779,146 payments
• Zimmer Biomet Holdings, Inc. 3.9% of the year $128,468,494 · 30,992 payments
• Stryker Corporation 3.6% of the year $120,144,264 · 148,619 payments
• Medtronic, Inc. 3.5% of the year $117,718,052 · 335,833 payments
• Arthrex, Inc. 3.5% of the year $114,714,931 · 47,935 payments
• Intuitive Surgical, Inc. 2.2% of the year $71,978,704 · 112,664 payments
• DePuy Synthes Products, Inc. 1.8% of the year $58,988,307 · 1,993 payments
• Genentech, Inc. 1.8% of the year $58,363,769 · 3,320 payments
• AstraZeneca Pharmaceuticals LP 1.7% of the year $57,247,929 · 464,707 payments
• Takeda Pharmaceuticals U.S.A., Inc. 1.7% of the year $55,483,057 · 145,802 payments
• Genzyme Corporation 1.4% of the year $46,855,161 · 162,739 payments
• Boston Scientific Corporation 1.4% of the year $46,425,640 · 231,819 payments
• Abbott Laboratories 1.3% of the year $42,380,026 · 317,396 payments
• Smith+Nephew, Inc. 1.2% of the year $41,400,678 · 68,433 payments
• Lilly USA, LLC 1.2% of the year $38,832,604 · 507,395 payments
• Pfizer Inc. 1.1% of the year $36,770,354 · 515,138 payments
• Gilead Sciences, Inc. 1.1% of the year $36,066,156 · 111,662 payments
• GlaxoSmithKline, LLC. 1.1% of the year $35,405,444 · 439,057 payments
• E.R. Squibb & Sons, L.L.C. 0.9% of the year $31,150,362 · 207,201 payments
• AstraZeneca UK Limited 0.8% of the year $27,518,345 · 2,521 payments
• Amgen Inc. 0.8% of the year $26,813,892 · 376,215 payments
• Merck Sharp & Dohme Corporation 0.7% of the year $23,355,830 · 243,910 payments
• Janssen Biotech, Inc. 0.7% of the year $23,113,451 · 257,833 payments
• Encore Medical, LP 0.7% of the year $22,461,859 · 5,459 payments
• Atricure, Inc. 0.7% of the year $22,418,637 · 25,162 payments
• Novo Nordisk Inc 0.7% of the year $22,019,837 · 485,855 payments
• Regeneron Healthcare Solutions, Inc. 0.7% of the year $21,727,879 · 149,667 payments
• Medical Device Business Services, Inc. 0.6% of the year $20,145,872 · 26,304 payments
• NuVasive, Inc. 0.6% of the year $19,682,765 · 12,833 payments
• Boehringer Ingelheim Pharmaceuticals, Inc. 0.6% of the year $19,143,070 · 206,484 payments
• LivaNova USA, Inc. 0.5% of the year $18,054,445 · 7,897 payments
• Novartis Pharmaceuticals Corporation 0.5% of the year $17,691,929 · 378,124 payments
• Align Technology, Inc. 0.5% of the year $17,089,930 · 55,681 payments
• Horizon Therapeutics plc 0.5% of the year $17,064,066 · 70,794 payments
• Globus Medical, Inc. 0.5% of the year $16,424,193 · 17,458 payments
• Edwards Lifesciences Corporation 0.5% of the year $16,328,082 · 63,236 payments
• Siemens Medical Solutions USA, Inc. 0.5% of the year $15,930,282 · 10,976 payments
• Janssen Pharmaceuticals, Inc 0.5% of the year $15,911,529 · 209,118 payments
• CSL Plasma Inc. 0.5% of the year $15,772,622 · 11,752 payments
• Zimvie Inc. 0.5% of the year $15,739,468 · 47,628 payments
• Neurocrine Biosciences, Inc. 0.5% of the year $15,684,941 · 85,346 payments
• Incyte Corporation 0.4% of the year $14,516,991 · 72,085 payments
• AngioDynamics, Inc. 0.4% of the year $14,488,798 · 12,254 payments
• Galderma Laboratories, L.P. 0.4% of the year $14,335,830 · 45,682 payments
• Otsuka America Pharmaceutical, Inc. 0.4% of the year $13,853,961 · 180,251 payments
• Alphatec Spine, Inc 0.4% of the year $13,110,979 · 6,156 payments
• Alcon Vision LLC 0.4% of the year $13,091,175 · 94,553 payments
• Alkermes, Inc. 0.4% of the year $13,031,180 · 95,111 payments
• Biogen, Inc. 0.4% of the year $12,677,569 · 33,937 payments